Cargando…

ODP119 Raloxifene use after denosumab discontinuation partially attenuates bone loss in the lumbar spine in postmenopausal osteoporosis

PURPOSE: Discontinuation of denosumab (DMab) is associated with rapid declinein bone density. Sequential antiresorptive drugs are recommended to preserve bone mass after DMab treatment. It remains unclear whether raloxifene exclusively can be used in certain conditions to attenuate bone loss after D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hone, Namki, Kim, Kyoungjin, Lee, Seunghyun, Rhee, Yumie, Shin, Sungjae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Bone & Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624547/ http://dx.doi.org/10.1210/jendso/bvac150.361

Ejemplares similares

OR13-06 Romosozumab After Denosumab Improves Lumbar Spine Bone Mineral Density And Microarchitecture Greater Than Denosumab Continuation In Postmenopausal Women
por: Hong, Namki, et al.
Publicado: (2023)

ODP132 Efficacy of Romosozumab for Osteoporosis in a Patient with Hajdu-Cheney Syndrome: A Case Report
por: Kim, Kyoung Jin, et al.
Publicado: (2022)

ODP104 Isolated familial hypoparathyroidism with Tbx1 mutation in Korea
por: Lee, Seunghyun, et al.
Publicado: (2022)

ODP077 Adipopenia is associated with low bone mass in community-dwelling non-underweight adults, independent of sarcopenia
por: Lee, Seunghyun, et al.
Publicado: (2022)

Circulating Lipocalin-2 Predicts Changes in Lumbar Spine Bone Mineral Density After Parathyroidectomy in Primary Hyperparathyroidism
por: Lee, Seunghyun, et al.
Publicado: (2021)

Comparative Transcriptomic Profiling Revealed Distinctive Patterns in Differentially Expressed Genes Related to Clinicopathologic Features of Parathyroid Carcinoma and Adenoma
por: Hong, Namki, et al.
Publicado: (2021)

ODP085 Denosumab Induced Severe Hypophosphatemia
por: Del Mar Morales Hernandez, Maria, et al.
Publicado: (2022)

Circulating MicroRNA-23a-5p Is a Potential Biomarker for Recovery of Bone Mass After Parathyroidectomy in Primary Hyperparathyroidism
por: Lee, Seunghyun, et al.
Publicado: (2021)

An Observational Study to Assess the Safety and Efficacy on Quality of Life and Patient Satisfaction With Raloxifene/Cholecalciferol Combination Therapy in Postmenopausal Women Requiring Prevention or Treatment for Osteoporosis
por: Chung, Yoon-Sok, et al.
Publicado: (2021)

ODP084 Denosumab as a therapuetic modality in management of primary hyperparathyroidism induced severe hypercalcemia
por: Mangaraj, Swayamsidha, et al.
Publicado: (2022)

ODP595 Case Series Of Idiopathic Hypercalciuria And Secondary Osteoporosis
por: Mirza, Fayal, et al.
Publicado: (2022)

SAT-532 Bisphosphonates Prevent Bone Loss Associated with Denosumab Treatment Discontinuation
por: Zanchetta, Maria Belen, et al.
Publicado: (2019)

THU448 Multiple Non-traumatic Vertebral Fractures After Discontinuation Of Denosumab
por: Riahi, Shayan, et al.
Publicado: (2023)

SUN-391 Denosumab Treatment of Patients with Osteoporosis and Idiopathic Hypercalciuria
por: Chu, Winston S, et al.
Publicado: (2020)

THU445 Complicated Course And Management After Denosumab Discontinuation: A Case Report
por: Arora, Ipsa, et al.
Publicado: (2023)

SUN-377 Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Real World, Prospective Observational Study
por: Khan, Aliya Aziz, et al.
Publicado: (2020)

ODP090 Fragility Fractures and Osteoporosis Screening in Patients with Chronic Lymphocytic Leukemia
por: Petty, Lloyd, et al.
Publicado: (2022)

FRI685 Denosumab Withdrawal Is Associated With Hypercalcemia In Adults With Osteoporosis And Bone Metastases
por: Patil, Madhuri D, et al.
Publicado: (2023)

OR01-5 Transition From Low Dose Denosumab 30mg to IV Zoledronic Acid: Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis: A Prospective Observational Study
por: Ibrahim, Quazi, et al.
Publicado: (2022)

ODP599 Modulation of Wnt/b-catenin and Autophagy in an in vitro Model of Glucocorticoid-induced Osteoporosis
por: Mannino, Federica, et al.
Publicado: (2022)

ODP080 Bisphosphonate treatment for osteoporosis in children with Gorham-Stout syndrome: a case report
por: Ahn, Moon Bae, et al.
Publicado: (2022)

SUN-512 Denosumab Improves Trabecular but Not Cortical Bone Osteoporosis in a Patient with Refractory Primary Hyperparathyroidism
por: Alhassan, Sharifa, et al.
Publicado: (2019)

Efficacy of Low Dose Denosumab in Maintaining Bone Mineral Density in Postmenopausal Women With Osteoporosis Switching From 60mg to 30mg 6 Monthly: A Real World, Prospective Observational Study
por: Khan, Aliya, et al.
Publicado: (2021)

Machine Learning-Derived Simple Score Predicts the Risk of Tertiary Hyperparathyroidism Requiring Surgical Treatment Among Kidney Transplant Recipients: The DPC score
por: Hong, Namki, et al.
Publicado: (2021)

ODP083 Burosumab Treatment for Fibrous dysplasia/McCune-Albright Syndrome with Severe Spine Deformity
por: Sato, Tetsuhiko, et al.
Publicado: (2022)

ODP092 Guideline Adherence for Age-based Screening of Osteoporosis in Men at a Veterans Affairs Medical Center
por: Alsamarraie, Henin, et al.
Publicado: (2022)

ODP070 A deep learning-based osteopenia and osteoporosis screening system with lateral lumbar spine X-ray in women aged 50 years or older and men aged 60 years or older
por: Chung, Yoon-Sok, et al.
Publicado: (2022)

Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women
por: Ha, J., et al.
Publicado: (2022)

ODP093 Hunt for Hypercalcemia
por: Wang, Ally W, et al.
Publicado: (2022)

SUN-390 Computed Tomography Derived Skeletal Muscle Radiodensity Is Better Predictor of Muscle Power Than Skeletal Muscle Area in Community-Dwelling Older Adults
por: Choi, Heewon, et al.
Publicado: (2020)

MON-LB71 Adult Hypophosphatasia and Postmenopausal Osteoporosis: A Challenging Case
por: Abramof-Ness, Rosane, et al.
Publicado: (2020)

ODP115 Primary Hyperparathyroidism in Pregnancy
por: Rosado-Burgos, Alexandra, et al.
Publicado: (2022)

ODP071 A Fit of Hypophosphatemia
por: Naha, Sowjanya, et al.
Publicado: (2022)

ODP274 Shift work is associated with normal weight obesity in community-dwelling adults
por: Ahn, Chul Woo, et al.
Publicado: (2022)

ODP131 Zoledronic acid and red eye
por: Patel, Urja, et al.
Publicado: (2022)

SAT-499 Denosumab for Treatment of Hypercalcemia in Myelofibrosis
por: Wong, Beatrice, et al.
Publicado: (2019)

MON-356 Atypical Femur Fracture with Denosumab
por: Mirza, Faryal S, et al.
Publicado: (2020)

ODP592 Delay in Diagnosis of Adult with Familial Hypophosphatasia
por: Choe, Chlarles, et al.
Publicado: (2022)

ODP078 An Unsolved Mystery of Hyperparathyroidism for 12 Years
por: Pant, Nicole, et al.
Publicado: (2022)

OR03-1 The Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
por: Lane, Nancy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n118l0np9hechd64nj0nn3hia7